Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Mianserin

Summary

Persistence. It cannot be excluded that mianserin is persistent, due to lack of data.

Bioaccumulation. It cannot be excluded that mianserin bioaccumulates, due to lack of data.

Toxicity. It cannot be excluded that mianserin is toxic, due to lack of data.

Risk. Risk of environmental impact of mianserin cannot be excluded, due to the lack of environmental toxicity data.

 

Environmental information is missing on fass.se for mianserin (2025-11-11).

Detailed information

Pharmaceuticals residues in the aquatic environment in Region Stockholm

Mianserin has previously been included in the selection of pharmaceutical substances analyzed in the aquatic environment within Region Stockholm, Sweden. The most recent sampling was conducted in 2021, when concentrations were below the quantification limit.

References

  1. IVL Swedish Environmental Research Institute Ltd Fick J, Lindberg RH, Fång J, Magnér J, Kaj L, Brorström-Lundén E. Screening 2014. Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. Rapport C 135.
  2. Goodpoint. Prioritering av läkemedel med miljörisk inom SLL. Stockholm: Goodpoint; 2016. Rapport LS 2016–0634.
  3. Provtagningar av läkemedelsrester i vatten, sediment och fisk för Region Stockholm.

Author: Health and Medical Care Administration, Region Stockholm